Merck

We are proud to present long-term data in HPV at EUROGIN 2026, reinforcing our commitment to patients. Learn more: go.merck.com/~oa6

We’re presenting new data from our pipeline at #ACC26, highlighting our continued focus on deepening our understanding of two serious diseases that impact the heart and lungs. Learn more here: go.merck.com/~4s6

Today, we presented new Phase 3 #KidneyCancer data that underscore the potential of a new treatment option in adjuvant #RCC. Learn more about the results shared at ASCO #GU26: go.merck.com/~8zg

In collaboration with @EisaiUS, we announced results highlighting the potential of our combination treatment for certain patients with advanced renal cell carcinoma (#RCC). Learn more about our data at ASCO #GU26. go.merck.com/~31u

We presented new data for our #immunotherapy in platinum-resistant #OvarianCancer, reinforcing our dedication across women’s cancers and our continuous effort to advance research where it's needed most. Learn more: go.merck.com/~l2r

Today, we presented positive data from our Phase 3 study in certain people with muscle-invasive bladder cancer. These data were shared at ASCO #GU26 in collaboration with @pfizer and @AstellasUS. Learn more: go.merck.com/~51y

At #CROI2026 we announced new results from three Phase 3 trials for our investigational treatment for HIV. Learn more: go.merck.com/~sao

Today, we presented new respiratory syncytial virus (#RSV) research at the Respiratory Syncytial Virus Foundation’s annual global conference. Learn more about the data and our commitment to RSV research: go.merck.com/~xmc

We’re excited to share that we’ve entered into a new R&D collaboration to apply AI, advanced analytics and multimodal clinical data to support AI-enabled drug discovery and precision medicine. By combining @MayoClinic's extensive clinical and genomic insights with our AI and machine learning capabilities, we’ll help accelerate more precise therapies - starting with immunology and neurology - for patients around the world. go.merck.com/~02h

@JustaTexasGirl3 We're sorry to hear your frustration. Please contact our National Service Center at dpoc.usa@merck.com or 1.800.672.6372 and they can do their best to address your concern.

@Merck trying to advocate for my father to receive his chemo medication and the process has been difficult to navigate with lots of red tape. Need someone to reach out.

We’re showcasing new data from our broad #oncology portfolio and investigational pipeline at #GU26. Learn more about our commitment to helping patients with difficult-to-treat genitourinary cancers: go.merck.com/~r1h

Today, we announced the #FDA approval of new treatment options for certain patients with platinum-resistant recurrent #OvarianCancer — an area where choices have long been limited. Learn more: go.merck.com/~n88

@Ecsa20 Please contact our National Service Center at 1.800.672.6372 or dpoc.usa@merck.com so we can learn more about your situation. We also recommend you inform your doctor.

@Merck @moderna_tx Fix the irreversible side effects from Propecia !!! The side effects are pure torture

In collaboration with @moderna_tx, we announced five-year follow-up data from a Phase 2b study evaluating our investigational individualized neoantigen therapy in combination with immunotherapy for #melanoma, reinforcing our commitment to advance cancer research. Learn more here: merck.us/4bFbmVt

Join us today at 9 a.m. ET to learn more about our Q4 and full-year 2025 #earnings: go.merck.com/~k18 $MRK

Our Q4 and full-year 2025 #earnings results are live. Check out our full $MRK financial summary and key highlights: go.merck.com/~erc

@LivngGratfulMed The safety of our products is very important to us. We’d like to hear more from you. Please contact the National Service Center at dpoc.usa@merck.com or 1.800.672.6372.

@stkirsch I gave @Merck’s 2006 version of Gardasil in 2008 to my daughter, 14 yo. After third shot, developed fibromyalgia & sjogrens syndrome. Forever life changing, leading into opiate addiction as an adult. Immunity they had, altering hers forever.

Color me not surprised about the HPV vaccine. It's the most dangerous vaccine after the COVID vaccine.

@rudy_betrayed Hi. Thank you for reaching out. We'd like to hear more about your grandpa's experience. Please contact the National Service Center at dpoc.usa@merck.com or 1.800.672.6372 to give further details.

Jesse Watters: “How do you win the war on drugs if Americans love c*caine?” Vice President JD Vance: “Some people do like c*caine… It’s a major profit center for the Venezuelan cartels… For all the people that love c*caine, I am sorry, the president of the United States does not love c*caine. We encourage you to go to rehab, and we’re going to continue pursuing America’s interests.”

Today, we announced the completion of the acquisition of Cidara Therapeutics, diversifying our pipeline with a novel late-phase antiviral candidate being evaluated for the prevention of symptomatic influenza in certain individuals at high risk of complications. Learn More. merck.us/49cvAVf

Today, we announced the initiation of a Phase 3 trial for one of our investigational pipeline candidates in certain patients with advanced nonsquamous non-small cell #lungcancer. Learn more: merck.us/49dDYE0